However, these syndromic tumors have a different genetic driver within the MAP kinase pathway compared to most sporadic pilocytic astrocytomas and gangliogliomas which typically harbor BRAF fusion or mutation. This evidence concerns the gene BRAF and pilocytic astrocytoma.